MYH14 and cardiomyopathy: Based on the knowledge on myosin and its interaction with actin, molecules targeting myosin and its associated proteins have been utilized in clinical trials for prevention and early treatment of cardiomyopathies (Repetti, Toepfer, Seidman, & Seidman, 2019).